Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2672-2673. doi: 10.1007/s00259-021-05428-7. Epub 2021 Jun 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Niacinamide / analogs & derivatives
  • Oligopeptides
  • Positron Emission Tomography Computed Tomography*
  • Prospective Studies
  • Prostatic Neoplasms* / diagnostic imaging

Substances

  • Oligopeptides
  • PSMA-1007
  • Niacinamide